John A. Ward

Array ( [id] => 1587458 [patent_doc_number] => 06482405 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'In situ injection of antigen-presenting cells with genetically enhanced cytokine expression' [patent_app_type] => B1 [patent_app_number] => 09/395836 [patent_app_country] => US [patent_app_date] => 1999-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 7462 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482405.pdf [firstpage_image] =>[orig_patent_app_number] => 09395836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908047 [patent_doc_number] => 20010010814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'ADENOVIRAL VECTOR ENCODING PRO-APOPTOTIC BAX GENE AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/393173 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12389 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20010010814.pdf [firstpage_image] =>[orig_patent_app_number] => 09393173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525686 [patent_doc_number] => 20020192643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'NOVEL CARD PROTEINS INVOLVED IN CELL DEATH REGULATION' [patent_app_type] => new [patent_app_number] => 09/388221 [patent_app_country] => US [patent_app_date] => 1999-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23364 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192643.pdf [firstpage_image] =>[orig_patent_app_number] => 09388221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766120 [patent_doc_number] => 20030100520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'IMMUNOLOGICAL PROCESS AND CONSTRUCTS FOR INCREASING THE HDL CHOLESTEROL CONCENTRATION BY DNA VACCINATION' [patent_app_type] => new [patent_app_number] => 09/386591 [patent_app_country] => US [patent_app_date] => 1999-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16827 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100520.pdf [firstpage_image] =>[orig_patent_app_number] => 09386591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 667964 [patent_doc_number] => 07094201 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-22 [patent_title] => 'System and method for genetically treating cardiac conduction disturbances' [patent_app_type] => utility [patent_app_number] => 09/376317 [patent_app_country] => US [patent_app_date] => 1999-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 9703 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094201.pdf [firstpage_image] =>[orig_patent_app_number] => 09376317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388141 [patent_doc_number] => 06541036 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Treatment of tumors with oligonucleotides directed to insulin-like growth factor-I receptors (IGF-IR)' [patent_app_type] => B1 [patent_app_number] => 09/374712 [patent_app_country] => US [patent_app_date] => 1999-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11605 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541036.pdf [firstpage_image] =>[orig_patent_app_number] => 09374712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062869 [patent_doc_number] => 20020031496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'THERAPY FOR CELLULAR ACCUMULATION IN CHRONIC INFLAMMATORY DISEASES' [patent_app_type] => new [patent_app_number] => 09/363997 [patent_app_country] => US [patent_app_date] => 1999-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15522 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20020031496.pdf [firstpage_image] =>[orig_patent_app_number] => 09363997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 662536 [patent_doc_number] => 07101708 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-05 [patent_title] => 'Hematopoietic cell composition for use in transplantation' [patent_app_type] => utility [patent_app_number] => 09/744654 [patent_app_country] => US [patent_app_date] => 1999-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 29 [patent_no_of_words] => 18593 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/101/07101708.pdf [firstpage_image] =>[orig_patent_app_number] => 09744654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 243335 [patent_doc_number] => 07589069 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-09-15 [patent_title] => 'Replication-competent anti-cancer vectors' [patent_app_type] => utility [patent_app_number] => 09/351778 [patent_app_country] => US [patent_app_date] => 1999-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 26 [patent_no_of_words] => 18286 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589069.pdf [firstpage_image] =>[orig_patent_app_number] => 09351778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404261 [patent_doc_number] => 06299873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Method for improvement of radiation therapy of malignant tumors' [patent_app_type] => 1 [patent_app_number] => 9/334312 [patent_app_country] => US [patent_app_date] => 1999-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4693 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/299/06299873.pdf [firstpage_image] =>[orig_patent_app_number] => 334312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1082819 [patent_doc_number] => 06833268 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-21 [patent_title] => 'Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions' [patent_app_type] => B1 [patent_app_number] => 09/329582 [patent_app_country] => US [patent_app_date] => 1999-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 31079 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833268.pdf [firstpage_image] =>[orig_patent_app_number] => 09329582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403839 [patent_doc_number] => 06534482 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Expression vectors for stimulating an immune response and methods of using the same' [patent_app_type] => B1 [patent_app_number] => 09/311784 [patent_app_country] => US [patent_app_date] => 1999-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 56 [patent_no_of_words] => 53011 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534482.pdf [firstpage_image] =>[orig_patent_app_number] => 09311784 [rel_patent_id] =>[rel_patent_doc_number] =>)